The India Cements Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:18 pm

Quick Insight

The India Cements Ltd, with a current share price of 369, boasts a market capitalization of 11,411 Cr. Despite a low Price-to-earnings ratio, ROE of 8.83%, and ROCE of 5.49%, the company faces challenges with an operating profit margin of 8% and a net profit of -144 Cr. Its high level of borrowings at ₹1,165 Cr and negative interest coverage ratio of -0.65x raise concerns about financial leverage. Additionally, the low P/BV ratio of 0.84x indicates that the stock may be undervalued. Investors should closely monitor the company's ability to improve profitability and manage its debt levels to drive future growth and shareholder value.

Competitors of The India Cements Ltd

All Competitor Stocks of The India Cements Ltd

Quarterly Result

Last Updated: August 1, 2025, 10:25 am

Below is a detailed analysis of the quarterly data for The India Cements Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,025.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,197.00 Cr. (Mar 2025) to 1,025.00 Cr., marking a decrease of 172.00 Cr..
• For Expenses, as of Jun 2025, the value is 942.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,200.00 Cr. (Mar 2025) to 942.00 Cr., marking a decrease of 258.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from -3.00 Cr. (Mar 2025) to 83.00 Cr., marking an increase of 86.00 Cr..
• For OPM %, as of Jun 2025, the value is 8.00%. The value appears strong and on an upward trend. It has increased from 0.00% (Mar 2025) to 8.00%, marking an increase of 8.00%.
• For Other Income, as of Jun 2025, the value is -115.00 Cr.. The value appears to be declining and may need further review. It has decreased from 111.00 Cr. (Mar 2025) to -115.00 Cr., marking a decrease of 226.00 Cr..
• For Interest, as of Jun 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 38.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 11.00 Cr..
• For Depreciation, as of Jun 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 75.00 Cr. (Mar 2025) to 74.00 Cr., marking a decrease of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -132.00 Cr.. The value appears to be declining and may need further review. It has decreased from -5.00 Cr. (Mar 2025) to -132.00 Cr., marking a decrease of 127.00 Cr..
• For Tax %, as of Jun 2025, the value is -1.00%. The value appears to be increasing, which may not be favorable. It has increased from -487.00% (Mar 2025) to -1.00%, marking an increase of 486.00%.
• For Net Profit, as of Jun 2025, the value is -133.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to -133.00 Cr., marking a decrease of 151.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -4.29. The value appears to be declining and may need further review. It has decreased from 0.47 (Mar 2025) to -4.29, marking a decrease of 4.76.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:13 pm

Below is a detailed analysis of the balance sheet data for The India Cements Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 310.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 310.00 Cr..
• For Reserves, as of Mar 2025, the value is 9,884.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,265.00 Cr. (Mar 2024) to 9,884.00 Cr., marking an increase of 4,619.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,165.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,633.00 Cr. (Mar 2024) to 1,165.00 Cr., marking a decrease of 1,468.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2,471.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,493.00 Cr. (Mar 2024) to 2,471.00 Cr., marking a decrease of 22.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 13,830.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,701.00 Cr. (Mar 2024) to 13,830.00 Cr., marking an increase of 3,129.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 11,638.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,874.00 Cr. (Mar 2024) to 11,638.00 Cr., marking an increase of 4,764.00 Cr..
• For CWIP, as of Mar 2025, the value is 177.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2024) to 177.00 Cr., marking a decrease of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 120.00 Cr.. The value appears to be declining and may need further review. It has decreased from 319.00 Cr. (Mar 2024) to 120.00 Cr., marking a decrease of 199.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,895.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,318.00 Cr. (Mar 2024) to 1,895.00 Cr., marking a decrease of 1,423.00 Cr..
• For Total Assets, as of Mar 2025, the value is 13,830.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,701.00 Cr. (Mar 2024) to 13,830.00 Cr., marking an increase of 3,129.00 Cr..

Notably, the Reserves (9,884.00 Cr.) exceed the Borrowings (1,165.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for The India Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 153.23. This value is within the healthy range. It has increased from -7.32 (Mar 24) to 153.23, marking an increase of 160.55.
• For Diluted EPS (Rs.), as of Mar 25, the value is 153.23. This value is within the healthy range. It has increased from -7.32 (Mar 24) to 153.23, marking an increase of 160.55.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.46. This value is within the healthy range. It has increased from 0.31 (Mar 24) to 3.46, marking an increase of 3.15.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 328.95. It has increased from 180.68 (Mar 24) to 328.95, marking an increase of 148.27.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 328.95. It has increased from 180.68 (Mar 24) to 328.95, marking an increase of 148.27.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 133.87. It has decreased from 164.97 (Mar 24) to 133.87, marking a decrease of 31.10.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -5.60. This value is below the healthy minimum of 2. It has decreased from 5.28 (Mar 24) to -5.60, marking a decrease of 10.88.
• For PBIT / Share (Rs.), as of Mar 25, the value is -13.33. This value is below the healthy minimum of 0. It has decreased from -1.99 (Mar 24) to -13.33, marking a decrease of 11.34.
• For PBT / Share (Rs.), as of Mar 25, the value is -5.53. This value is below the healthy minimum of 0. It has increased from -8.50 (Mar 24) to -5.53, marking an increase of 2.97.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -4.26. This value is below the healthy minimum of 2. It has increased from -6.96 (Mar 24) to -4.26, marking an increase of 2.70.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.64. This value is below the healthy minimum of 2. It has increased from -7.34 (Mar 24) to -4.64, marking an increase of 2.70.
• For PBDIT Margin (%), as of Mar 25, the value is -4.18. This value is below the healthy minimum of 10. It has decreased from 3.20 (Mar 24) to -4.18, marking a decrease of 7.38.
• For PBIT Margin (%), as of Mar 25, the value is -9.95. This value is below the healthy minimum of 10. It has decreased from -1.20 (Mar 24) to -9.95, marking a decrease of 8.75.
• For PBT Margin (%), as of Mar 25, the value is -4.12. This value is below the healthy minimum of 10. It has increased from -5.15 (Mar 24) to -4.12, marking an increase of 1.03.
• For Net Profit Margin (%), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has increased from -4.22 (Mar 24) to -3.18, marking an increase of 1.04.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -3.46. This value is below the healthy minimum of 8. It has increased from -4.44 (Mar 24) to -3.46, marking an increase of 0.98.
• For Return on Networth / Equity (%), as of Mar 25, the value is -1.40. This value is below the healthy minimum of 15. It has increased from -4.07 (Mar 24) to -1.40, marking an increase of 2.67.
• For Return on Capital Employeed (%), as of Mar 25, the value is -3.28. This value is below the healthy minimum of 10. It has decreased from -0.78 (Mar 24) to -3.28, marking a decrease of 2.50.
• For Return On Assets (%), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 5. It has increased from -2.12 (Mar 24) to -1.03, marking an increase of 1.09.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 0.2. It has decreased from 0.25 (Mar 24) to 0.10, marking a decrease of 0.15.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.11. This value is within the healthy range. It has decreased from 0.46 (Mar 24) to 0.11, marking a decrease of 0.35.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has decreased from 0.46 (Mar 24) to 0.33, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 1.5. It has increased from 0.99 (Mar 24) to 1.37, marking an increase of 0.38.
• For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.77 (Mar 24) to 0.92, marking an increase of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 4. It has increased from 1.38 (Mar 24) to 1.40, marking an increase of 0.02.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -0.65. This value is below the healthy minimum of 3. It has decreased from 0.67 (Mar 24) to -0.65, marking a decrease of 1.32.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.33. This value is below the healthy minimum of 3. It has decreased from -0.05 (Mar 24) to -1.33, marking a decrease of 1.28.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,628.90. It has increased from 9,137.60 (Mar 24) to 9,628.90, marking an increase of 491.30.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.32. This value is within the healthy range. It has increased from 1.79 (Mar 24) to 2.32, marking an increase of 0.53.
• For EV / EBITDA (X), as of Mar 25, the value is -55.44. This value is below the healthy minimum of 5. It has decreased from 55.80 (Mar 24) to -55.44, marking a decrease of 111.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 2.07, marking an increase of 0.78.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 1.18 (Mar 24) to 0.84, marking a decrease of 0.34.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 2.07, marking an increase of 0.78.
• For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.03 (Mar 24) to -0.01, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness